Accéder au contenu
Merck

Neonatal Escherichia coli K1 meningitis causes learning and memory impairments in adulthood.

Journal of neuroimmunology (2014-05-27)
Tatiana Barichello, Valdemira S Dagostim, Jaqueline S Generoso, Lutiana R Simões, Diogo Dominguini, Cintia Silvestre, Monique Michels, Márcia Carvalho Vilela, Luciano K Jornada, Clarissa M Comim, Felipe Dal-Pizzol, Antonio Lucio Teixeira, João Quevedo
RÉSUMÉ

Neonatal Escherichia coli meningitis continues to be an important cause of mortality and morbidity in newborns worldwide. The aim of this study was to investigate the cytokines/chemokines, brain-derived neurotrophic factor (BDNF) levels, blood-brain barrier integrity in neonatal rats following E. coli K1 experimental meningitis infection and subsequent behavioural parameters in adulthood. In the hippocampus, interleukin increased at 96 h, IL-6 at 12, 48 and 96 h, IL-10 at 96 h, cytokine-induced neutrophil chemoattractant-1 at 6, 12, 24, 48 and 96 h, and BDNF at 48 and 96 h. In the cerebrospinal fluid, tumour necrosis factor alpha levels increased at 6, 12, 24, 48 and 96 h. The BBB breakdown occurred at 12 h in the hippocampus, and at 6h in the cortex. We evaluated behavioural parameters in adulthood: habituation to the open-field, step-down inhibitory avoidance, object recognition, continuous multiple-trials step-down inhibitory avoidance and forced swimming tasks. In adulthood, the animals showed habituation and aversive memory impairment. The animals needed a significant increase in the number of training periods to learn and not had depressive-like symptoms.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Ceftriaxone disodium salt hemi(heptahydrate), third-generation cephalosporin antibiotic
Supelco
Ceftriaxone Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Ceftriaxone sodium, United States Pharmacopeia (USP) Reference Standard
Ceftriaxone sodium, European Pharmacopoeia (EP) Reference Standard